PMID: 8584317Oct 1, 1995Paper

Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease

The Pediatric Infectious Disease Journal
I R Friedland

Abstract

The continued spread of penicillin-resistant pneumococci raises therapeutic concerns. Optimal therapy for resistant infections is unknown and it is not clear whether the efficacy of penicillin or equally active beta-lactam agents is compromised in non-meningeal-resistant infections. A prospective nonintervention study was undertaken to compare the clinical response in penicillin-resistant vs. penicillin-susceptible bacteremic pneumococcal infections, excluding meningitis. Of 108 children enrolled, 35 (32%) had penicillin-resistant (one highly resistant) isolates. Seventy-eight children had pneumonia, 21 had occult bacteremia (sepsis) and 9 had peritonitis. Children with resistant infections were more likely to have underlying disorders, especially human immunodeficiency virus infection, and to have received antimicrobial therapy in the previous month. After 48 hours of therapy 64% of penicillin-susceptible infections showed improvement vs. 60% of penicillin-resistant infections (odds ratio, 1.2; 95% confidence intervals, 0.5 to 3.0). In children with pneumonia treated with ampicillin or an equivalent beta-lactam agent, 93% with penicillin-susceptible infections had improved by Day 7 of therapy compared with 88% with resistant i...Continue Reading

Citations

Mar 25, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R Dagan
May 1, 1997·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D GendrelG Kalifa
Dec 14, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J D FullerD E Low
Feb 8, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J Garau
Nov 30, 2000·Current Infectious Disease Reports·P RochaA R Tunkel
Jul 27, 2001·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·H PaganiniG Berberian
Jul 24, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Susanna Esposito, Nicola Principi
Jul 20, 2002·The Lancet Infectious Diseases·Javier Garau
Jul 15, 2003·Respirology : Official Journal of the Asian Pacific Society of Respirology·Chong Chia YinChay Oh Moh
Feb 8, 2002·The New England Journal of Medicine·Kenneth McIntosh
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A E FioreA Schuchat
Mar 18, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J P MetlayR F Breiman
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E Vuori-Holopainen, H Peltola
Aug 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J F MoroneyA Schuchat
Jan 26, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas M File
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellUNKNOWN Infectious Diseases Society of America
Feb 7, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jörg J RuheRodrigo Hasbun
Mar 5, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Javier AspaUNKNOWN Pneumococcal Pneumonia in Spain Study Group
Dec 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christine C Chiou
Jul 1, 1997·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·J C Butler
Feb 13, 1999·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·R PallaresF Gudiol
Sep 21, 2000·The Journal of Antimicrobial Chemotherapy·L Mandell
Aug 15, 2008·Journal of Tropical Pediatrics·Ming-Han TsaiTzou-Yien Lin
Mar 1, 1996·MCN. the American Journal of Maternal Child Nursing·S M Burke
Jun 1, 1996·The Pediatric Infectious Disease Journal·K L O'Brien, B Schwartz
Nov 1, 1996·The Pediatric Infectious Disease Journal·E N BerezinC K Farhat
Mar 1, 1997·The Pediatric Infectious Disease Journal·U B Schaad
Apr 1, 1997·The Pediatric Infectious Disease Journal·S L Block
Feb 10, 1999·The Pediatric Infectious Disease Journal·M SilversteinM B Harper
Apr 27, 2000·The Pediatric Infectious Disease Journal·G H McCracken
Sep 23, 2000·The Pediatric Infectious Disease Journal·G H McCracken
May 8, 2004·The Pediatric Infectious Disease Journal·Blanca E GonzalezSheldon L Kaplan
Jul 13, 2004·The Pediatric Infectious Disease Journal·Gustavo GiachettoAna María Ferrari
Feb 8, 2006·The Pediatric Infectious Disease Journal·Alexander M Holston, James R Miller
Aug 1, 1997·Journal of Paediatrics and Child Health·K GrimwoodP B McIntyre
Feb 15, 2007·Respirology : Official Journal of the Asian Pacific Society of Respirology·Wen C ChiangOh M Chay
Sep 14, 2000·Australian and New Zealand Journal of Medicine·J G McCormack
Sep 14, 2000·Australian and New Zealand Journal of Medicine·K E Rowland, J D Turnidge
Mar 21, 2001·Antimicrobial Agents and Chemotherapy·H ErlendsdottirS Gudmundsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Meningitis (ASM)

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Meningitis

Bacterial meningitis continues to be an important cause of mortality and morbidity throughout the world. Here is the latest research.